These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

910 related items for PubMed ID: 28500800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
    Kateete DP, Kamulegeya R, Kigozi E, Katabazi FA, Lukoye D, Sebit SI, Abdi H, Arube P, Kasule GW, Musisi K, Dlamini MG, Khumalo D, Joloba ML.
    BMC Pulm Med; 2019 Jul 10; 19(1):124. PubMed ID: 31291943
    [Abstract] [Full Text] [Related]

  • 4. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS, Kim YJ, Kang HY, Kim CK, Cho SY, Lee HJ.
    Infect Genet Evol; 2017 Apr 10; 49():111-115. PubMed ID: 28062386
    [Abstract] [Full Text] [Related]

  • 5. Pattern and characteristics of mutations conferring resistance to second line drugs in Mycobacterium tuberculosis isolates of pulmonary and extrapulmonary TB samples.
    Dixit R, Mohan E, Gupta A, Patni T.
    Indian J Tuberc; 2024 Apr 10; 71 Suppl 1():S37-S43. PubMed ID: 39067953
    [Abstract] [Full Text] [Related]

  • 6. Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
    Habibnia S, Karami-Zarandi M, Zaker S, Ghalavand Z, Doustdar F, Eslami G, Kazemian H.
    Clin Lab; 2023 Jan 01; 69(1):. PubMed ID: 36649505
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.
    Bablishvili N, Tukvadze N, Shashkina E, Mathema B, Gandhi NR, Blumberg HM, Kempker RR.
    Antimicrob Agents Chemother; 2017 Sep 01; 61(9):. PubMed ID: 28630205
    [Abstract] [Full Text] [Related]

  • 9. Genetic Characterization of Second-Line Drug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis from the Northern Region of India.
    Yadav R, Saini A, Mankotia J, Khaneja R, Agarwal P, Sethi S.
    J Epidemiol Glob Health; 2018 Dec 01; 8(3-4):220-224. PubMed ID: 30864767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Ei PW, Aung WW, Nyunt WW, Swe TL, Htwe MM, Win SM, Aung ST, Chang CL, Lee HY, Lee JS.
    Int J Tuberc Lung Dis; 2018 Jan 01; 22(1):47-53. PubMed ID: 29297425
    [Abstract] [Full Text] [Related]

  • 12. Performance of the MTBDRsl assay in Georgia.
    Tukvadze N, Bablishvili N, Apsindzelashvili R, Blumberg HM, Kempker RR.
    Int J Tuberc Lung Dis; 2014 Feb 01; 18(2):233-9. PubMed ID: 24429319
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C, Perdigão J, Jordão L, Portugal I.
    Int J Antimicrob Agents; 2014 Dec 01; 44(6):546-51. PubMed ID: 25270633
    [Abstract] [Full Text] [Related]

  • 16. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
    Dymova MA, Cherednichenko AG, Alkhovik OI, Khrapov EA, Petrenko TI, Filipenko ML.
    BMC Infect Dis; 2014 Sep 03; 14():478. PubMed ID: 25186134
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Said HM, Kock MM, Ismail NA, Mphahlele M, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.
    J Clin Microbiol; 2012 Sep 03; 50(9):2857-62. PubMed ID: 22649019
    [Abstract] [Full Text] [Related]

  • 18. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
    Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB.
    PLoS One; 2013 Sep 03; 8(2):e55299. PubMed ID: 23390524
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.